Skip to main content
FinSpry Logo
FinSpry
SHC logo
SHC
(NASDAQ)
Sotera Health Company
$19.51-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Sotera Health Company (SHC) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Sotera Health Company stock.

Analyst Consensus Rating

Investment consensus from 5 professional research analysts

Consensus Rating

Buy
Based on 5 unique analysts
Medium Confidence∞:1 Buy/Sell

Average Price Target

$21.60
↑ 10.71% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest SHC Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Luke Sergott
Barclays
BuyReiterates
$18.00 → $19.00
Jason Bednar
Piper Sandler
BuyMaintains
$22.00
Evie Koslosky
Goldman Sachs
BuyInitiates
$20.00
Patrick B Donnelly
Citi
BuyMaintains
$23.00
Ryan Halsted
RBC Capital
BuyReiterates
$24.00

Frequently Asked Questions

What is the analyst consensus rating for SHC?

The analyst consensus rating for SHC is "Buy" based on 5 analyst recommendations.

What is the average price target for SHC?

The average 12-month price target for SHC is $21.60, representing an upside of 10.7% from the current price of $19.51.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.